Business Disruption Caused by COVID-19
First written in FY2020. 7 of 14 entries say "Materialised", first in FY2021-Q2. Latest entry: FY2024.
Takada moved to the "Worse" side of this theme in 2020, the same year as the typical company in this theme.
The whole theme swung hardest in 2025: 4 of 13 companies on the "Worse" side.
4 other companies' latest entry also says "Reframed".
- FY2024ReframedAnnual report
「If novel infectious diseases or other illnesses spread in areas surrounding the locations of our Group and disrupt our business activities, or if the resulting human impact expands, this may affect the performance of our Group.」
The description shifted from one centred on COVID-19 to the more generalised risk expression “novel infectious diseases and other illnesses.” - FY2024-Q1MitigatedAnnual report
「During the three-month period ended June 30 of the current fiscal year, Japan's economy continued to recover moderately, supported by the effects of various policies amid improvements in employment and income conditions, in addition to the reclassification of COVID-19 as a Class 5 infectious disease.」
The reclassification of COVID-19 as a Class 5 infectious disease and the recovery in economic conditions were described, indicating signs of easing in the disruption to economic activity caused by infectious disease. - FY2023-Q3MitigatedAnnual report
「During the nine-month period ended December 31 of the current fiscal year, Japan's economy continued to show signs of recovery as progress was made in balancing measures against COVID-19 with economic activity.」
It was stated that progress was made in balancing measures against infectious disease with economic activity and that the recovery in economic conditions continued. - FY2023-Q2MitigatedAnnual report
「During the six-month period ended September 30 of the current fiscal year, Japan's economy showed signs of recovery as restrictions on movement related to COVID-19 were gradually eased and economic activity moved toward normalisation, partly due to the effects of various policies.」
It was stated that restrictions on movement related to infectious disease were gradually eased, while economic activity moved toward normalisation and economic conditions recovered. Concerns about a renewed spread of infectious disease were indicated separately. - FY2023-Q1MitigatedAnnual report
「During the three-month period ended June 30 of the current fiscal year, Japan's economy showed signs of recovery, supported by the easing of restrictions on economic activity accompanying a decline in the number of COVID-19 cases and the effects of various policies.」
The easing of restrictions on economic activity accompanying a decline in the number of cases and the recovery in economic conditions were described, indicating signs of easing in the disruption to economic activity caused by infectious disease. - FY2022MaterialisedAnnual report
「However, in Southeast Asia, where our Group has its operating bases, economic activity was restricted by COVID-19, affecting our business activities.」
Restrictions on economic activity in Southeast Asia caused by COVID-19 and their impact on business activities also occurred over the full fiscal year. - FY2022-Q3MaterialisedAnnual report
「As a result, regarding sales during the nine-month period ended December 31 of the current fiscal year, consolidated net sales amounted to ¥32.955 billion, due to a decrease in periodic maintenance work at chemical plants and restrictions on activities in regions where our overseas subsidiaries are located as a result of the impact of COVID-19.」
Restrictions on activities in regions where our overseas subsidiaries are located due to COVID-19, together with a decrease in periodic maintenance work at chemical plants, became factors behind the decline in net sales. - FY2022-Q2MaterialisedAnnual report
「Under these circumstances, our Group continued to pursue the basic policies and business direction of the medium-term management plan through the previous fiscal year and worked to strengthen the foundations of each business, but activities in regions where our overseas subsidiaries are located were restricted due to the impact of COVID-19.」
Restrictions on activities in regions where our overseas subsidiaries are located continued due to COVID-19, affecting business activities during the six-month period ended September 30 of the current fiscal year. - FY2022-Q1MaterialisedAnnual report
「Regarding earnings, consolidated operating income amounted to ¥181 million, consolidated ordinary income to ¥190 million, and net income attributable to owners of the parent to ¥93 million, due mainly to the continued restrictions on activities in regions where our overseas subsidiaries are located as a result of the impact of COVID-19 and an increase in the provision for loss on construction contracts.」
The continued restrictions on activities in regions where our overseas subsidiaries are located due to COVID-19 became a factor behind the decline in earnings. - FY2021MaterialisedAnnual report
「However, in Southeast Asia, where we have our operating bases, economic activity was restricted by COVID-19, significantly affecting our business activities.」
Restrictions on economic activity in Southeast Asia caused by COVID-19 significantly affected overseas business activities over the full fiscal year. - FY2021-Q3MaterialisedAnnual report
「As a result, regarding sales during the nine-month period ended December 31 of the current fiscal year, consolidated net sales amounted to ¥36.328 billion, down 5.0% year on year, due mainly to restrictions on activities in regions where our overseas subsidiaries are located as a result of the impact of COVID-19.」
Restrictions on activities in regions where our overseas subsidiaries are located due to COVID-19 resulted in a business impact, with net sales declining 5.0% year on year. - FY2021-Q2MaterialisedAnnual report
「Regarding sales during the six-month period ended September 30 of the current fiscal year, consolidated net sales amounted to ¥24.884 billion, down 7.7% year on year, due mainly to restrictions on activities in regions where our overseas subsidiaries are located as a result of the impact of COVID-19.」
Restrictions on activities in regions where our overseas subsidiaries are located due to COVID-19 resulted in an actual business impact, with net sales declining 7.7% year on year. - FY2021-Q1WorsenedAnnual report
「During the cumulative first quarter under review, Japan's economy remained in an extremely difficult situation as demand continued to stagnate due to restrictions on economic activity resulting from the impact of COVID-19. The timing of the end of the pandemic remains uncertain, and economic activity is unstable.」
Weak demand and economic instability caused by COVID-19 have continued, and the impact of infectious disease risk has materialised in the business environment. - FY2020First statedAnnual report
「If infectious diseases such as COVID-19 spread in areas surrounding the locations of our Group and disrupt our business activities, or if the resulting human impact expands, this may affect the performance of our Group.」
Business disruption and expanding human impact caused by the spread of infectious diseases such as COVID-19 were first explicitly identified as a standalone business risk.